MedPath

LIDOCAINE 7% / TETRACAINE 7%

LIDOCAINE 7% / TETRACAINE 7%

Approved
Approval ID

8915c505-4cf6-7f0a-e053-2995a90a8395

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 17, 2019

Manufacturers
FDA

Sincerus Florida, LLC

DUNS: 080105003

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LIDOCAINE 7% / TETRACAINE 7%

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72934-5142
Product Classification
G
Generic Name
LIDOCAINE 7% / TETRACAINE 7%
Product Specifications
Route of AdministrationTOPICAL
Effective DateMay 17, 2019
FDA Product Classification

INGREDIENTS (2)

LIDOCAINEActive
Quantity: 7 g in 100 g
Code: 98PI200987
Classification: ACTIB
TETRACAINEActive
Quantity: 7 g in 100 g
Code: 0619F35CGV
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LIDOCAINE 7% / TETRACAINE 7% - FDA Drug Approval Details